Clinical UM Guideline |
Subject: Wheeled Mobility Devices: Manual Wheelchairs-Ultra Lightweight | |
Guideline #: CG-DME-33 | Publish Date: 01/03/2024 |
Status: Reviewed | Last Review Date: 11/09/2023 |
Description |
This document addresses criteria for ultra-lightweight wheelchairs. Manual wheeled mobility devices or wheelchairs are generally used by individuals with neurological, orthopedic, or cardiopulmonary conditions who cannot achieve independent or assisted movement with devices such as canes and walkers. The appropriate type of wheelchair is determined by assessment and evaluation of body size, medical needs and physical deficits. An ultra- lightweight manual wheelchair is constructed of high strength materials and weighs less than 30 lbs.
Note: Please see the following related documents for additional information:
Clinical Indications |
Medically Necessary:
An ultra lightweight manual wheelchair is considered medically necessary when all of the following are met:
Repair and replacement of an ultra lightweight manual wheelchair is considered medically necessary when needed for normal wear or accidental damage.
Not Medically Necessary:
Ultra lightweight manual wheelchairs are considered not medically necessary for any of the following:
Modifications to the structure of the home environment to accommodate the device (for example, widening doors, lowering counters) are considered not medically necessary.
Coding |
The following codes for treatments and procedures applicable to this document are included below for informational purposes. Inclusion or exclusion of a procedure, diagnosis or device code(s) does not constitute or imply member coverage or provider reimbursement policy. Please refer to the member’s contract benefits in effect at the time of service to determine coverage or non-coverage of these services as it applies to an individual member.
When services may be Medically Necessary when criteria are met:
HCPCS |
|
K0005 | Ultralightweight wheelchair |
|
|
ICD-10 Diagnosis |
|
All diagnoses |
When services are Not Medically Necessary:
For the procedure code listed above when criteria are not met or for situations designated in the Clinical Indications section as not medically necessary.
Discussion/General Information |
The Centers for Medicare and Medicaid Services (CMS, 2005) Mobility Assistive Equipment National Coverage Decision (NCD), which considers the clinical indications for the appropriate types of mobility assistive devices were utilized in the development of this document.
Mobility impairments include a broad range of disabilities that affect a person’s independent movement and cause limited mobility. In 2022, the National Center for Medical Rehabilitation Research (NCMRR) Program, estimates that 31 million people have mobility impairments, which may take the form of paralysis, muscle weakness, nerve damage, stiffness of the joints, or balance/coordination deficits. According to the Centers for Disease Control and Prevention (2020) there are three dimensions of disability: impairment, activity limitations, and participation restrictions. In the Americans with Disabilities Act the census estimated that over 4% of the United States population has moderate to severe disability requiring an individual to use a wheelchair to assist with mobility. Nearly 4 million Americans, aged 15 years and older are required to use a wheelchair (National Census Bureau, 2012).
Selecting an ultra lightweight manual wheelchair is individualized and must consider the user’s impairment, level of function, medical condition, surrounding environment, activity level, seating and positioning needs.
In 2009, Salminen and colleagues performed a systematic review of the literature to determine the effectiveness of mobility assistive devices. The review found that mobility devices improve users’ participation and mobility however it was not possible to draw any general conclusions about the effectiveness of mobility device interventions. The authors emphasized that well-designed research is required to accurately assess the effectiveness of mobility assistive devices.
Souza and colleagues (2010) found that 68% of those with multiple sclerosis (MS) used wheelchairs for mobility assistance. This disease causes a wide variety of neurological deficits with ambulatory impairment being the first symptom and most common form of disability in those with MS. The authors found only a limited number of articles with higher levels of evidence addressing mobility assistance specifically for persons with MS and concluded that further research is necessary to develop an accurate assessment and measurable clinical performance model addressing the use of mobility assistive devices for the different aspects of MS-related motor impairments.
Cherubini and colleague (2012) conducted an observational study of 150 wheelchair users (n=80 men, n=70 women) with an average age of 46.7 ± 17.3 years, to analyze the congruence of the prescribed wheelchair and the individual’s mobility needs. The individuals had varied disabilities, 24% spinal cord injury, multiple sclerosis 18%, cerebral infantile paralysis 18% and skull trauma 10%. The authors found that 68% of the prescribed wheelchairs were not suitable in reference to the wheelchair and accessories. After finding a correlation between the prescription sources and the suitability of the wheelchair for the individual, it was concluded that wheelchair prescriptions should be based on careful assessment of mobility needs and improved collaboration between physicians and technicians.
Definitions |
Activities of daily living (ADLs): Self-care activities such as transfers, toileting, grooming and hygiene, dressing, bathing, and eating.
Functional mobility: The ability to consistently move safely and efficiently, with or without the aid of appropriate assistive devices (such as prosthetics, orthotics, canes, walkers, wheelchairs, etc.), at a reasonable rate of speed to complete an individual’s typical mobility-related activities of daily living. Functional mobility can be altered by deficits in strength, endurance sufficient to complete tasks, coordination, balance, speed of execution, pain, sensation, proprioception, range of motion, safety, shortness of breath, and fatigue.
References |
Peer Reviewed Publications:
Government Agency, Medical Society and Other Authoritative Publications:
Index |
Ultra Lightweight Wheelchair
Wheelchair
History |
Status | Date | Action |
Reviewed | 11/09/2023 | Medical Policy & Technology Assessment Committee (MPTAC) review. Revised grammatical error in Definitions Section. Updated References Section. |
Reviewed | 11/10/2022 | MPTAC review. Updated Description, Discussion and References sections. |
Reviewed | 11/11/2021 | MPTAC review. Updated Discussion and References sections. |
Reviewed | 11/05/2020 | MPTAC review. Updated References section. Reformatted Coding section. |
Reviewed | 11/07/2019 | MPTAC review. Updated Discussion and References sections. |
Reviewed | 01/24/2019 | MPTAC review. Updated References section. |
Reviewed | 02/27/2018 | MPTAC review. The document header wording updated from “Current Effective Date” to “Publish Date.” Updated grammatical error in discussion and ADLs definition. Updated Reference section. |
Revised | 02/02/2017 | MPTAC review. Removed “Note” below medically necessary criteria for repairs and replacement for ultra-lightweight manual wheelchairs. Updated formatting in clinical indications section. Updated Discussion and Reference sections. |
Revised | 02/04/2016 | MPTAC review. Clarified medically necessary criteria for ultra-lightweight manual wheelchairs. Reformatted clinical indication section. Added note to medically necessary criteria for repairs and replacement for ultra-lightweight manual wheelchairs. Updated References. Removed ICD-9 codes from Coding section. |
Revised | 02/05/2015 | MPTAC review. Reformatted medically necessary and not medically necessary statements. Clarified medically necessary assessment criteria. Updated Description and References. |
Reviewed | 02/13/2014 | MPTAC review. Updated Websites. |
Revised | 02/14/2013 | MPTAC review. Reformatted not medically necessary statement. Updated Description, References and Websites. |
Reviewed | 02/16/2012 | MPTAC review. Discussion and References updated. |
Reviewed | 02/17/2011 | MPTAC review. Discussion and References updated. |
New | 02/25/2010 | MPTAC. Initial document development to specifically address ultra-lightweight manual wheelchairs formerly contained in CG-DME-24. |
Pre-Merger Organizations | Last Review Date | Document Number | Title |
Anthem Virginia | 06/28/2002 | Memo 1103 | Wheelchairs |
Anthem CO/NV | 10/29/2004 | DME.205 | Motorized/Power Wheelchair Bases |
Anthem CO/NV | 10/29/2004 | DME.206 | Wheelchair Options & Accessories |
Anthem CO/NV | 10/29/2004 | DME.207 | Wheelchair Seating |
Anthem CO/NV | 10/29/2004 | DME.208 | Power Operated Vehicles |
Anthem Connecticut | 09/2004 | Guideline | DME Guidelines |
Anthem Connecticut | 11/2004 | Guideline | DME Guidelines Summary |
Anthem Midwest | 05/27/2005 | DME 006 | Wheelchairs: Manual, Motorized Powered, And Accessories |
Anthem Midwest | 05/27/2005 | DME 022 | Power Operated Vehicles |
WellPoint Health Networks, Inc. | 09/23/2004 | Guideline | Motorized Assistive Devices |
Federal and State law, as well as contract language, and Medical Policy take precedence over Clinical UM Guidelines. We reserve the right to review and update Clinical UM Guidelines periodically. Clinical guidelines approved by the Medical Policy & Technology Assessment Committee are available for general adoption by plans or lines of business for consistent review of the medical necessity of services related to the clinical guideline when the plan performs utilization review for the subject. Due to variances in utilization patterns, each plan may choose whether to adopt a particular Clinical UM Guideline. To determine if review is required for this Clinical UM Guideline, please contact the customer service number on the member's card.
Alternatively, commercial or FEP plans or lines of business which determine there is not a need to adopt the guideline to review services generally across all providers delivering services to Plan’s or line of business’s members may instead use the clinical guideline for provider education and/or to review the medical necessity of services for any provider who has been notified that his/her/its claims will be reviewed for medical necessity due to billing practices or claims that are not consistent with other providers, in terms of frequency or in some other manner.
No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic, mechanical, photocopying, or otherwise, without permission from the health plan.
© CPT Only - American Medical Association